Chronic Active Liver Disease Reexamined: Prognosis Hopeful (Q39937073)

15 September 2017

1 reference

title

Chronic Active Liver Disease Reexamined: Prognosis Hopeful (English)

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

9 February 2023

1 reference

W. H. Summerskill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4591728

9 February 2023

language of work or name

English

0 references

publication date

1 March 1974

1 reference

full work available at URL

15 September 2017

https://api.elsevier.com/content/article/PII:S0016508574801472?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

https://api.elsevier.com/content/article/PII:S0016508574801472?httpAccept=text/plain

9 February 2023

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

9 February 2023

1 reference

15 September 2017

volume

66

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

450-464

1 reference

15 September 2017

cites work

Active chronic hepatitis

3

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

A classification of chronic hepatitis

9 February 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy

9 February 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

9 February 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Controlled trial of prednisone and azathioprine in active chronic hepatitis

9 February 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Chronic Active Liver Disease: Classification and Treatment

9 February 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Chronic active hepatitis in children.

9 February 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Chronic active hepatitis and Graves' disease

9 February 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Cholestasis in active chronic hepatitis.

9 February 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Chronic hepatitis and cirrhosis of the liver in cryoglobulinaemia

9 February 2023

21

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Dysimmunoglobulinemia associated with hepatobiliary disorders

9 February 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Anti-Salmonella agglutinins in chronic active liver disease

9 February 2023

25

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Mitochondrial Antibody in Primary Biliary Cirrhosis and Other Diseases

9 February 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Hepatobiliary diseases associated with serum antimitochondrial antibody (AMA).

9 February 2023

27

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Association between polyarteritis and Australia antigen

9 February 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa

9 February 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane

9 February 2023

30

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Prognosis of chronic persistent hepatitis

9 February 2023

31

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Prognosis of chronic hepatitis. 1. Forms and developmental stages

9 February 2023

32

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Abnormal bile duct epithelium in chronic aggressive hepatitis and primary biliary cirrhosis

9 February 2023

33

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Chronic hepatitis as a first manifestation of Wilson's disease

9 February 2023

34

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.

9 February 2023

35

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

9 February 2023

Isoniazid hepatitis

36

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Drug-induced active chronic hepatitis

9 February 2023

37

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Long-incubation (virus B, HAA-associated) hepatitis

9 February 2023

38

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Australia antigen in chronic active liver disease with cirrhosis

9 February 2023

39

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Australia antigen in acute and chronic liver disease.

9 February 2023

40

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Natural history of hepatitis-associated antigen-positive chronic liver disease

9 February 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Incidence and Meaning of Persistence of Australia Antigen in Patients with Acute Viral Hepatitis: Development of Chronic Hepatitis

9 February 2023

44

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Differential distribution of Australia-antigen-associated particles in patients with liver diseases and normal carriers

9 February 2023

45

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Detection of a new serum-antigen in three epidemics of short-incubation hepatitis

9 February 2023

47

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Autoimmune aspects of liver disease

9 February 2023

48

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Cellular immunity and hepatitis-associated, Australia antigen liver disease

9 February 2023

49

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Chronic Hepatitis — Migration Inhibition of Leukocytes in the Presence of Australia Antigen

9 February 2023

50

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen

9 February 2023

51

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Liver disease and cell-mediated immunity in hepatitis-associated antigen (HAA) carriers

9 February 2023

52

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

9 February 2023

Autoallergic Hepatitis

53

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Australia Antigen in Chronic Hepatitis in Australia

9 February 2023

54

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Relation between Australia antigen and autoimmune hepatitis

9 February 2023

56

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Australia antigen and smooth-muscle antibody in acute and chronic hepatitis

9 February 2023

58

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen

9 February 2023

59

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease

9 February 2023

61

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies

9 February 2023

62

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Association of autoimmune active chronic hepatitis with HL-A1,8.

9 February 2023

65

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

The immunology of liver disease

9 February 2023

66

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Albumin and immunoglobulin turnover in patients with chronic active liver disease treated with prednisone

9 February 2023

67

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

9 February 2023

68

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein binding

9 February 2023

70

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine

9 February 2023

72

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Splenectomy in Active Chronic Hepatitis

9 February 2023

74

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Long-term results of therapy in patients with chronic liver disease associated with hypergammaglobulinemia

9 February 2023

75

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Faecal antigen in viral hepatitis.

9 February 2023

77

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Menstrual blood as a vehicle of Australia-antigen transmission

9 February 2023

78

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Australia antigen and antibody among patients attending a clinic for sexually transmitted diseases

9 February 2023

79

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Spread of acute type-B hepatitis in London

9 February 2023

80

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Hepatitis B antigen in saliva and mouth washings

9 February 2023

81

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Hepatitis-Associated Antigen (Australia Antigen) in Mother and Infant

9 February 2023

82

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

Management of the asymptomatic carrier of the hepatitis-associated (Australia) antigen. Tentative considerations of the clinical and public-health aspects

9 February 2023

83

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(74)80147-2

9 February 2023

Identifiers

1 reference